191 related articles for article (PubMed ID: 2410574)
21. After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer.
Feuer EJ; Frey CM; Brawley OW; Nayfield SG; Cunningham JB; Geller NL; Bosl GJ; Kramer BS
J Clin Oncol; 1994 Feb; 12(2):368-77. PubMed ID: 7509384
[TBL] [Abstract][Full Text] [Related]
22. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program.
Vugrin D; Whitmore WF; Golbey RB
J Urol; 1982 Dec; 128(6):1205-8. PubMed ID: 6185697
[TBL] [Abstract][Full Text] [Related]
23. Reassessment of the role of adjunctive surgical therapy in the treatment of advanced germ cell tumors.
Carter GE; Lieskovsky G; Skinner DG; Daniels JR
J Urol; 1987 Dec; 138(6):1397-401. PubMed ID: 2446018
[TBL] [Abstract][Full Text] [Related]
24. Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor.
Kawai K; Hinotsu S; Oikawa T; Sekido N; Hattori K; Miyanaga N; Hasegawa Y; Kojima H; Shimazui T; Akaza H
Jpn J Clin Oncol; 2006 Nov; 36(11):723-30. PubMed ID: 17082218
[TBL] [Abstract][Full Text] [Related]
25. [Chemotherapy of testicular tumors].
Cortes Funes H; Leiva Galvis O
Actas Urol Esp; 1981; 5(5):259-72. PubMed ID: 6174033
[No Abstract] [Full Text] [Related]
26. [Advanced non-seminoma germinal tumors of the testicle. Therapeutic strategy and method of action of chemotherapy].
Bassoulet J; Raoul Y; Garetta L
Ann Urol (Paris); 1986; 20(1):35-42. PubMed ID: 2423016
[TBL] [Abstract][Full Text] [Related]
27. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
28. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
[TBL] [Abstract][Full Text] [Related]
29. Malignant ovarian germ cell tumors: the experience at the Hospital de la Santa Creu i Sant Pau.
Germá JR; Izquierdo MA; Seguí MA; Climent MA; Ojeda B; Alonso C
Gynecol Oncol; 1992 May; 45(2):153-9. PubMed ID: 1375576
[TBL] [Abstract][Full Text] [Related]
30. VAB-3 combination chemotherapy in primary mediastinal germ cell tumors.
Vugrin D; Martini N; Whitmore WF; Golbey RB
Cancer Treat Rep; 1982 Jun; 66(6):1405-7. PubMed ID: 6177411
[TBL] [Abstract][Full Text] [Related]
31. Surgical treatment of patients with stages I and II nonseminomatous testicular cancer.
Fraley EE; Narayan P; Vogelzang NJ; Kennedy BJ; Lange PH
J Urol; 1985 Jul; 134(1):70-3. PubMed ID: 2409301
[TBL] [Abstract][Full Text] [Related]
32. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
33. [Preliminary evaluation of the toxicity and effectiveness of chemotherapy using the VAB-6 protocol in the treatment of non-seminoma of the testis].
Madej G; Gigier A; Siedlecki P; Pieńkowski T
Nowotwory; 1987; 37(1):44-9. PubMed ID: 2442730
[No Abstract] [Full Text] [Related]
34. A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial.
Fizazi K; Do KA; Wang X; Finn L; Logothetis CJ; Amato RJ
Ann Oncol; 2002 Jan; 13(1):125-34. PubMed ID: 11863094
[TBL] [Abstract][Full Text] [Related]
35. Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis.
Hartmann JT; Einhorn L; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Schmoll HJ; Kanz L; Bokemeyer C
J Clin Oncol; 2001 Mar; 19(6):1641-8. PubMed ID: 11250992
[TBL] [Abstract][Full Text] [Related]
36. Therapy of extragonadal germ-cell tumors.
Daugaard G; Rørth M; Hansen HH
Eur J Cancer Clin Oncol; 1983 Jul; 19(7):895-9. PubMed ID: 6192996
[TBL] [Abstract][Full Text] [Related]
37. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group.
Williams SD; Blessing JA; Moore DH; Homesley HD; Adcock L
Ann Intern Med; 1989 Jul; 111(1):22-7. PubMed ID: 2472080
[TBL] [Abstract][Full Text] [Related]
39. Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors.
Motzer RJ; Cooper K; Geller NL; Pfister DG; Lin SY; Bajorin D; Scher HI; Herr H; Fair W; Morse M
Cancer; 1990 Jun; 65(11):2465-70. PubMed ID: 1692505
[TBL] [Abstract][Full Text] [Related]
40. Intensive chemotherapy for metastatic nonseminomatous germ cell tumors.
Logothetis CJ; Chong C; Dexeus FH; Sella A; Ogden S
Prog Clin Biol Res; 1990; 350():301-7. PubMed ID: 1696741
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]